Literature DB >> 32900676

Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.

Riccardo Mastroianni1, Ado Brassetti2, Wojciech Krajewski3, Romuald Zdrojowy3, Yazan Al Salhi4, Umberto Anceschi2, Alfredo Maria Bove2, Antonio Carbone4, Cosimo De Nunzio5, Andrea Fuschi4, Mariaconsiglia Ferriero2, Antonio Nacchia5, Antonio Luigi Pastore4, Giorgia Tema5, Gabriele Tuderti2, Michele Gallucci6, Giuseppe Simone2.   

Abstract

BACKGROUND: Obtaining detrusor muscle (DM) in transurethral resection of bladder tumor (TURBt) specimen is considered a surrogate marker of resection quality. However, evidence was principally investigated in high-risk tumors. Therefore, DM sampling for low-grade (LG) urothelial carcinoma (UC) remains poorly investigated and certainly requires further investigation.
OBJECTIVE: To assess whether the absence of DM in TURBt specimen has a negative impact on recurrence-free survival (RFS) in patients with a Ta LG UC. DESIGN, SETTING, AND PARTICIPANTS: A multicenter TURBt database was queried for "LG, Ta, UC of the bladder." All patients treated between 1996 and 2018 with tumor grade assessed according to both 1973 World Health Organization and 2004 WHO/International Society of Urological Pathology grading classifications and with a minimum follow-up of 1 yr were included. Patients with a previous history of high-grade UC, upper urinary tract UC, or bladder tumor differentiations other than UC were excluded. INTERVENTION: TURBt. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Baseline demographic, clinical, and pathologic data were analyzed. The European Organization for Research and Treatment of Cancer (EORTC) risk group was recorded. Kaplan-Meier analysis was performed to assess the predictive role of clinical and pathologic data for RFS. Univariable and multivariable Cox regression analyses were performed to identify the predictors of recurrence. RESULTS AND LIMITATIONS: Overall, 521 patients were included. At Kaplan-Meier analysis, the low-risk cohort displayed significantly higher RFS than the intermediate-risk cohort (1-yr RFS 87% vs 79%; log-rank p = 0.007). At univariable Cox regression analysis, only gender, multiple tumors, tumor diameter ≥3 cm, and EORTC risk group were significant predictors of recurrence. Absence of DM had no impact on RFS. Multivariable Cox regression analysis confirmed gender and EORTC risk group as independent predictors of recurrence.
CONCLUSIONS: Absence of DM in TURBt specimen has negligible role in RFS of patients with Ta LG tumors of the bladder. PATIENT
SUMMARY: In this study, we assessed the role that detrusor muscle (DM) in transurethral resection of bladder tumor specimen has in recurrence-free survival, in patients with a Ta low-grade urothelial carcinoma of the bladder. Absence of DM has no impact on tumor recurrence; therefore, it does not require additional attention.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Detrusor muscle; Intermediate-risk bladder cancer; Low-grade bladder cancer; Low-risk bladder cancer; Non–muscle-invasive bladder cancer; Recurrence-free survival; Transurethral resection of the bladder

Mesh:

Year:  2020        PMID: 32900676     DOI: 10.1016/j.euf.2020.08.007

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  4 in total

1.  Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.

Authors:  Bimal Bhindi; Ronald Kool; Girish S Kulkarni; D Robert Siemens; Armen G Aprikian; Rodney H Breau; Fadi Brimo; Adrian Fairey; Christopher French; Nawar Hanna; Jonathan I Izawa; Louis Lacombe; Victor McPherson; Ricardo A Rendon; Bobby Shayegan; Alan I So; Alexandre R Zlotta; Peter C Black; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2021-08       Impact factor: 1.862

2.  Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study.

Authors:  Giovanni Tarantino; Felice Crocetto; Concetta Di Vito; Massimiliano Creta; Raffaele Martino; Savio Domenico Pandolfo; Salvatore Pesce; Luigi Napolitano; Domenico Capone; Ciro Imbimbo
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

Review 3.  Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis.

Authors:  Jiangnan Xu; Zhenyu Xu; HuMin Yin; Jin Zang
Journal:  Front Surg       Date:  2022-09-14

4.  Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy.

Authors:  Reza Sari Motlagh; Victor M Schuettfort; Keiichiro Mori; Satoshi Katayama; Pawel Rajwa; Abdulmajeed Aydh; Nico C Grossmann; Ekaterina Laukhtina; Benjamin Pradere; Hadi Mostafai; Fahad Quhal; Mohammad Abufaraj; Richard Lee; Pierre I Karakiewicz; Yair Lotan; Eva Comprate; Marco Moschini; Paolo Gontero; Shahrokh F Shariat
Journal:  Int J Urol       Date:  2022-04-02       Impact factor: 2.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.